Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOXYNE LIMITED Director's Dealing 2016

May 4, 2016

64594_rns_2016-05-04_fee67cfc-0390-466f-9a66-53ef8ccda595.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: Bioxyne Limited

ABN: 97 084 464 193

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of Corporations Act.

Name of Director
Anthony Peng Ho
Date of last notice
16 March 2016

Part 1 – Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust.

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct & Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
Individual (Direct)
Individual trustee and member of
A.P. & C.H. Ho A/C> (Indirect)
Date of change 05 May 2016
No. of securities held prior to change Direct
Indirect
8,900,000
190,000
1,000,000
fully paid ordinary shares
fully paid ordinary shares
options expiring
10 December 2017
Class Ordinary
Number acquired 1,000,000
Number disposed -
Value/Consideration
Note: If consideration is non-cash, provide details and
estimated valuation.
$21,000.00
No. of securities held after change Direct
Indirect
8,900,000
1,190,000
fully paid ordinary shares
fully paid ordinaryshares
  • See chapter 19 for defined terms.

Appendix 3B Page 1

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Nature of change Exercise of 1,000,000 options held under A.P. & Example: on-market trade, off-market trade, exercise of C.H. Ho options, issue of securities under dividend reinvestment plan, for a total cash consideration of $21,000 on 5 participation in buy-back May 2016

Part 2 – Change of director’s relevant interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
Date of change N/A
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in relation to which
the interest is changed
N/A
Interest acquired N/A
Interest disposed N/A
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
N/A
Interest after change N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed
above traded during a+closed period where prior
written clearance was required?
No
If so, was prior written clearance provided to allow the
trade to proceed during this period?
N/A
If prior written clearance was provided, on what date
was this provided?
N/A

See chapter 19 for defined terms.

Appendix 3B Page 2

01/01/2011